Feb 2020 @auManufacturing

sleep deviceHearing implant group Cochlear has increased its investment in a start-up business developing a device to combat obstructive sleep apnea. Apnea, a market dominated by Cochlear’s Australian rival ResMed, has attracted a number of competing devices with healthcare company Nyxoah pursuing a novel approach.

The company’s device (pictured) stimulates the tongue nerve during sleep, triggering the nerve to contract the tongue. A minimally invasive surgical procedure to implant a neurostimulator is part of the treatment. Cochlear first invested 13 million Euros in Nyxoah in 2018 which has been revalued at $35.8 million. Now the Sydney company has invested a further $13 million as part of a much larger round of funding. Cochlear made the investments through its innovation fund.

Become a Member

Become a Cicada member
For only A$10 for life, you will receive a copy of Buzz magazine and can attend events.

Latest News

Vinaora Visitors Counter

089220
Today
Yesterday
This Week
Last Week
This Month
Last Month
All days
1828
4087
17520
38298
89220
0
89220

Your IP: 54.36.148.3
20-01-2021 11:57

Deafblindness

Here is a link to Deafblindness support and information.
They are based in Western Australia and supported by Senses Australia.

Hear For You logo

 

 

 

Hear For You web site

Vision Statement: “For all young people who are deaf to reach their potential in life.”

Go to top
JSN Boot template designed by JoomlaShine.com
Web Analytics